AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway

Oncology Letters - Greece
doi 10.3892/ol.2019.11175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2020English

miR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy Through the PTEN/PI3K/AKT Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

IGFBP-3 Methylation-Derived Deficiency Mediates the Resistance to Cisplatin Through the Activation of the IGFIR/Akt Pathway in Non-Small Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway

Cancer Management and Research
Oncology
2020English

B7-H3 Induces Ovarian Cancer Drugs Resistance Through an PI3K/AKT/BCL-2 Signaling Pathway

Cancer Management and Research
Oncology
2019English

MKRN2 Inhibits Migration and Invasion of Non-Small-Cell Lung Cancer by Negatively Regulating the PI3K/Akt Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

P007 LPCAT1 Promotes Brain Metastasis of Non-Small Cell Lung Cancer Cells by Up-Regulating PI3K/AKT/MYC Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy